Through analyzing the role of PRMT1 in tumorigenesis and immune cell infiltration for patients in TCGA (see methods for details), we found PRMT1 was highly expressed in most cancer types, including breast cancer (BRCA, Supplementary Fig. 4a). The gene discussed is PRMT1; the disease is breast carcinoma.